Firibastat is a prodrug of two brain aminopeptidase A inhibitors, developed to treat resistant hypertension. It failed to show efficacy in a Phase III trial.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.